Teva Pharmaceuticals recalls Octreotide Acet: 1000 mcg/5mL vials due to lack of assurance of sterility. This could lead to infections if used improperly.
Lack of Assurance of Sterility
Teva Pharmaceuticals is recalling Octreotide Acetate Injection 1000 mcg/5mL vials because they may not be sterile. This poses a risk of infection if the medication is used.
The vials may not be sterile, which could lead to infections if the medication is used. This is a risk for patients receiving the injection.
Patients prescribed this medication by a doctor are affected. Those using the product without medical supervision are not at risk.
Check for the product name 'Octreotide Acetate Injection 1000 mcg/5mL', 5 mL multi-dose vial, and the lot number 31329150B with expiration date 06/2022.
Look for the lot number 313291:329150B and expiration date 06/2022 on the vial.
The product may not be sterile, which could lead to infections. Do not use if you have the lot number 31329150B.
Check the lot number and expiration date. If it matches, contact your doctor for guidance.
The recall record does not specify a replacement process.
We’ve drafted a message you can send Teva Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0736-2021 — Teva Pharmaceuticals Teva Pharmaceuticals Hello, I own a Teva Pharmaceuticals that is covered by recall D-0736-2021 from Teva Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
